About: NatiVita

An Entity of Type: Public, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

NatiVita is an international research and manufacturing pharmaceutical company, it is situated in Beshankovichy urban settlement, Vitebsk region, Belarus. NatiVita is the first company in Belarus, that started developing and producing biopharmaceutical medicines based on monoclonal antibodies using target cell therapy for specific genetic diseases such as Breast cancer, Lung cancer, Myeloma. The company was established in 2012 with support of AB ZiaValda (Lithuania), «UniPharma» (Slovakia), «NatcoPharma Ltd» (India)

Property	Value
dbo:abstract	NatiVita is an international research and manufacturing pharmaceutical company, it is situated in Beshankovichy urban settlement, Vitebsk region, Belarus. NatiVita is the first company in Belarus, that started developing and producing biopharmaceutical medicines based on monoclonal antibodies using target cell therapy for specific genetic diseases such as Breast cancer, Lung cancer, Myeloma. The company was established in 2012 with support of AB ZiaValda (Lithuania), «UniPharma» (Slovakia), «NatcoPharma Ltd» (India) (en)
dbo:foundingYear	2012-01-01 (xsd:gYear)
dbo:thumbnail	wiki-commons:Special:FilePath/NatiVita's_logo.png?width=300
dbo:type	dbr:Public
dbo:wikiPageExternalLink	http://atom.belta.by/en/sciense_block/view/sciense_block/view/expert-belarus-can-take-its-pharma-industry-to-the-next-level-4619/t_id/1 http://sharkovshchina.vitebsk-region.gov.by/en/region-en/view/slovakia-takes-live-interest-in-pharmaceutical-enterprise-in-belarusian-beshenkovichi-14428/ http://www.nativita.com/ http://www.belarus.by/en/business/business-news/lithuanian-private-sector-eyeing-belarusian-pharmaceutics-with-interest_i_0000060747.html
dbo:wikiPageID	54822874 (xsd:integer)
dbo:wikiPageLength	3279 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID	1110379713 (xsd:integer)
dbo:wikiPageWikiLink	dbc:Pharmaceutical_companies_of_Belarus dbr:Public dbr:Belarus dbr:Beshankovichy dbr:Breast_cancer dbc:Pharmaceutical_companies_established_in_2012 dbr:Monoclonal_antibodies dbr:Lung_cancer dbc:Belarusian_companies_established_in_2012 dbr:Cell_therapy dbr:Genetic_diseases dbr:Myeloma dbr:File:NatiVita_main_office.jpg
dbp:foundation	2012 (xsd:integer)
dbp:homepage	http://www.nativita.com/
dbp:industry	Innovative medications research and developing (en)
dbp:logo	NatiVita's logo.png (en)
dbp:logoSize	250 (xsd:integer)
dbp:name	NatiVita (en)
dbp:type	dbr:Public
dbp:wikiPageUsesTemplate	dbt:Infobox_company dbt:Orphan dbt:Reflist dbt:Short_description
dcterms:subject	dbc:Pharmaceutical_companies_of_Belarus dbc:Pharmaceutical_companies_established_in_2012 dbc:Belarusian_companies_established_in_2012
rdf:type	owl:Thing dbo:Company schema:Organization dul:Agent dul:SocialPerson dbo:Agent wikidata:Q24229398 wikidata:Q43229 wikidata:Q4830453 dbo:Organisation
rdfs:comment	NatiVita is an international research and manufacturing pharmaceutical company, it is situated in Beshankovichy urban settlement, Vitebsk region, Belarus. NatiVita is the first company in Belarus, that started developing and producing biopharmaceutical medicines based on monoclonal antibodies using target cell therapy for specific genetic diseases such as Breast cancer, Lung cancer, Myeloma. The company was established in 2012 with support of AB ZiaValda (Lithuania), «UniPharma» (Slovakia), «NatcoPharma Ltd» (India) (en)
rdfs:label	NatiVita (en)
owl:sameAs	wikidata:NatiVita https://global.dbpedia.org/id/3cUD5
prov:wasDerivedFrom	wikipedia-en:NatiVita?oldid=1110379713&ns=0
foaf:depiction	wiki-commons:Special:FilePath/NatiVita's_logo.png wiki-commons:Special:FilePath/NatiVita_main_office.jpg
foaf:homepage	http://www.nativita.com/
foaf:isPrimaryTopicOf	wikipedia-en:NatiVita
foaf:name	NatiVita (en)
is foaf:primaryTopic of	wikipedia-en:NatiVita